Contents

Search

elosulfase alfa (Vimizim)

Indications: - Morquio A syndrome Dosage: - 2 mg/kg IV infused over a minimum of 3.5-4.5 hr - pretreat with antihistamines (with or without antipyretics) 30-60 minutes before initiating infusion Mechaninism of action: - enzyme replacement

General

metabolic agent (metabolic modifier)

References

  1. Medscape: elosulfase alfa (Rx) - Vimizim http://reference.medscape.com/drug/vimizim-elosulfase-alfa-999909